Skip to main content
GENIP PLC logo

GENIP PLC — Investor Relations & Filings

Ticker · GNIP ISIN · GB00BLCW2Q02 LEI · 213800E6CFHS4IG69P89 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 36 across all filing types
Latest filing 2024-11-20 Regulatory Filings
Country GB United Kingdom
Listing IL GNIP

About GENIP PLC

https://genip.ai/

GENIP PLC provides generative artificial intelligence (GenAI) analytic services designed to help organizations commercialize new discoveries and technologies. The company's target clients include corporations, research institutions, universities, and venture funds. It operates through two primary service offerings. 'Invention Evaluator' is a GenAI-enhanced platform used to rapidly assess the market potential and commercial opportunity of new innovations. This is complemented by 'Vortechs Executive', a specialized executive recruiting service that identifies and places leaders with proven experience in technology commercialization. By combining AI-driven analytics with human expertise, GENIP aims to bridge the gap between groundbreaking ideas and market success.

Recent filings

Filing Released Lang Actions
Corporate Update
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 8627M' and contains standard regulatory boilerplate language at the end, including references to 'RNS, the news service of the London Stock Exchange' and 'Market Abuse Regulations (EU) No 596/2014'. The content itself is a 'Corporate Update' detailing recent orders, new commercial agreements, and management commentary. This format—a brief, timely announcement of operational or commercial news disseminated via the RNS system—is characteristic of a general regulatory filing that doesn't fit a more specific category like 10-K, ER, or DIV. Since it is a general regulatory announcement disseminated through the RNS system, the most appropriate classification is Regulatory Filings (RNS). It is not an announcement of a report (RPA) because it contains substantive operational updates, not just a notice that a report is available.
2024-11-20 English
Healthcare Technology Event in Singapore
Regulatory Filings Classification · 1% confidence The document is identified by the RNS Number (3193M) and explicitly states it is a 'Reach announcement'. The text further clarifies that 'Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain.' It also notes that regulatory information would be disseminated as an RNS regulatory announcement, not via Reach. The content itself is a general corporate update congratulating a partner (NHIC) on an anniversary, which is non-material regulatory news. This fits the definition of a general regulatory announcement or non-regulatory news release distributed via the RNS system, making 'Regulatory Filings' (RNS) the most appropriate general category for this type of announcement that is explicitly stated not to be a formal regulatory filing under AIM Rules or Market Abuse Regulation.
2024-11-15 English
GenIP to Sponsor Technology Transfer Conference
Regulatory Filings Classification · 1% confidence The document is identified by the RNS Number '9971I' and contains an announcement dated October 22, 2024, regarding GenIP Plc's sponsorship and participation in an industry event (XVIII National Brazilian Forum of Innovation and Technology Transfer Managers - FORTEC). The text explicitly states, 'This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain.' Furthermore, it clarifies that information required under AIM Rules or Market Abuse Regulation would be disseminated as an RNS regulatory announcement, implying this specific document is non-regulatory news. Since it is a general announcement of company activity that is not a specific financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, CAP, DIRS), the most appropriate classification is the general regulatory/news announcement category, which is RNS, as it is distributed via the RNS platform but explicitly marked as non-regulatory news/media release.
2024-10-22 English
GenIP recognises Nobel Prize in Physics
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 6205H' and contains a date (10 October 2024). The content is a press release discussing company updates, recent business wins, market outlook related to Generative AI, and strategic goals. Crucially, the footer explicitly states: 'This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.' This indicates the document is a non-regulatory news release distributed via the RNS platform, which aligns best with the 'Regulatory Filings' (RNS) category, serving as the general regulatory/announcement fallback when a more specific category like ER, DIV, or CAP does not apply. It is not a full financial report (10-K, IR) or a specific voting/director/dividend announcement.
2024-10-10 English
Corporate Update
Earnings Release Classification · 1% confidence The document is identified by the header 'RNS Number : 2372H' and concludes with standard RNS distribution information, including a reference to the London Stock Exchange and the Market Abuse Regulations. The content provides a 'Corporate Update' detailing recent order wins and business developments since the launch of new services, which is typical for a company providing timely operational news to the market. Since this is a general, non-periodic update that doesn't fit the specific criteria for Earnings Release (ER), Interim Report (IR), or Director's Dealing (DIRS), and it is clearly a regulatory announcement distributed via RNS, the most appropriate classification is Regulatory Filings (RNS). The document length (8974 chars) is substantial enough that it is not merely an announcement of a report (RPA), but the report/update itself. FY 2023
2024-10-08 English
Admission to Trading on AIM-First Day of Dealings
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number : 5550G) on October 2, 2024. The primary subject is the 'Admission to Trading on AIM & First Day of Dealings' for GenIP PLC. It details the fundraising statistics (Placing Price, Gross proceeds, Market capitalisation), outlines the company strategy, use of proceeds, and lists the Board of Directors. This type of announcement, which details a significant corporate event (like an IPO or listing) and provides key financial/structural details, is a standard regulatory disclosure. Since it is not a full Annual Report (10-K), a Quarterly Report (IR), an Earnings Release (ER), or a specific proxy/voting document, and it is a formal announcement of a major corporate action (listing/fundraising), it fits best under the general 'Regulatory Filings' category (RNS) as a primary information provider announcement, although it contains elements of Capital/Financing Update (CAP). Given the context of RNS distribution and the nature of the announcement (Admission to Trading), RNS is the most appropriate general classification for this type of market notice.
2024-10-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.